160 related articles for article (PubMed ID: 24551272)
1. Potential biomarkers for sensitivity of gallbladder cancer cells to gemcitabine.
Yang C; Xu M; Shen HJ; Zhu HY; Li F; He M; Chen T; Wang J; Shi WJ; Ji F
Int J Clin Exp Pathol; 2014; 7(2):521-8. PubMed ID: 24551272
[TBL] [Abstract][Full Text] [Related]
2. Maslinic acid potentiates the antitumor activities of gemcitabine in vitro and in vivo by inhibiting NF-κB-mediated survival signaling pathways in human gallbladder cancer cells.
Yu Y; Wang J; Xia N; Li B; Jiang X
Oncol Rep; 2015 Apr; 33(4):1683-90. PubMed ID: 25633045
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of microRNA-205-5p exerts suppressive effects on stem cell drug resistance in gallbladder cancer by down-regulating PRKCE.
Zhang GF; Wu JC; Wang HY; Jiang WD; Qiu L
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32869841
[TBL] [Abstract][Full Text] [Related]
4. Array analysis for potential biomarker of gemcitabine identification in non-small cell lung cancer cell lines.
Zhang HH; Zhang ZY; Che CL; Mei YF; Shi YZ
Int J Clin Exp Pathol; 2013; 6(9):1734-46. PubMed ID: 24040438
[TBL] [Abstract][Full Text] [Related]
5. ELF3 promotes gemcitabine resistance through PKMYT1/CDK1 signaling pathway in gallbladder cancer.
Yang L; Wang H; Guo M; He M; Zhang W; Zhan M; Liu Y
Cell Oncol (Dordr); 2023 Aug; 46(4):1085-1095. PubMed ID: 36988891
[TBL] [Abstract][Full Text] [Related]
6. Ribonucleotide reductase subunit M1 is a possible chemoresistance marker to gemcitabine in biliary tract carcinoma.
Ohtaka K; Kohya N; Sato K; Kitajima Y; Ide T; Mitsuno M; Miyazaki K
Oncol Rep; 2008 Aug; 20(2):279-86. PubMed ID: 18636187
[TBL] [Abstract][Full Text] [Related]
7. [Mechanisms of the drug resistance of a 2', 2-difluorodeoxycytide (gemcitabine)-resistant variant of the human lung adenocarcinoma cell line].
Dong M; Feng FY; Lin C; Zhang XY; Fu M; Liang X; Zha YY; Lu HY; Wu M
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):323-8. PubMed ID: 15059518
[TBL] [Abstract][Full Text] [Related]
8. α-Mangostin suppresses the de novo lipogenesis and enhances the chemotherapeutic response to gemcitabine in gallbladder carcinoma cells via targeting the AMPK/SREBP1 cascades.
Shi Y; Fan Y; Hu Y; Jing J; Wang C; Wu Y; Geng Q; Dong X; Li E; Dong D
J Cell Mol Med; 2020 Jan; 24(1):760-771. PubMed ID: 31762191
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of autophagy by chloroquine enhances the antitumor activity of gemcitabine for gallbladder cancer.
Wang FT; Wang H; Wang QW; Pan MS; Li XP; Sun W; Fan YZ
Cancer Chemother Pharmacol; 2020 Aug; 86(2):221-232. PubMed ID: 32654071
[TBL] [Abstract][Full Text] [Related]
10. Calreticulin: a potential diagnostic and therapeutic biomarker in gallbladder cancer.
Ye J; Qi L; Du Z; Yu L; Chen K; Li R; Feng R; Zhai W
Aging (Albany NY); 2021 Feb; 13(4):5607-5620. PubMed ID: 33591948
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA SSTR5-AS1 facilitates gemcitabine resistance via stabilizing NONO in gallbladder carcinoma.
Xue Z; Yang B; Xu Q; Zhu X; Qin G
Biochem Biophys Res Commun; 2020 Feb; 522(4):952-959. PubMed ID: 31810606
[TBL] [Abstract][Full Text] [Related]
12. Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas.
Pignochino Y; Sarotto I; Peraldo-Neia C; Penachioni JY; Cavalloni G; Migliardi G; Casorzo L; Chiorino G; Risio M; Bardelli A; Aglietta M; Leone F
BMC Cancer; 2010 Nov; 10():631. PubMed ID: 21087480
[TBL] [Abstract][Full Text] [Related]
13. Identification of chemoresistance-related mRNAs based on gemcitabine-resistant pancreatic cancer cell lines.
Zhou J; Zhang L; Zheng H; Ge W; Huang Y; Yan Y; Zhou X; Zhu W; Kong Y; Ding Y; Wang W
Cancer Med; 2020 Feb; 9(3):1115-1130. PubMed ID: 31823522
[TBL] [Abstract][Full Text] [Related]
14. LncRNA HIF1A-AS1 Promotes Gemcitabine Resistance of Pancreatic Cancer by Enhancing Glycolysis through Modulating the AKT/YB1/HIF1α Pathway.
Xu F; Huang M; Chen Q; Niu Y; Hu Y; Hu P; Chen D; He C; Huang K; Zeng Z; Tang J; Wang F; Zhao Y; Wang C; Zhao G
Cancer Res; 2021 Nov; 81(22):5678-5691. PubMed ID: 34593522
[TBL] [Abstract][Full Text] [Related]
15. miR-1 and miR-145 act as tumor suppressor microRNAs in gallbladder cancer.
Letelier P; García P; Leal P; Álvarez H; Ili C; López J; Castillo J; Brebi P; Roa JC
Int J Clin Exp Pathol; 2014; 7(5):1849-67. PubMed ID: 24966896
[TBL] [Abstract][Full Text] [Related]
16. Intrinsic chemoresistance to gemcitabine is associated with decreased expression of BNIP3 in pancreatic cancer.
Akada M; Crnogorac-Jurcevic T; Lattimore S; Mahon P; Lopes R; Sunamura M; Matsuno S; Lemoine NR
Clin Cancer Res; 2005 Apr; 11(8):3094-101. PubMed ID: 15837765
[TBL] [Abstract][Full Text] [Related]
17. High infiltration of mast cells is associated with improved response to adjuvant chemotherapy in gallbladder cancer.
Bo X; Wang J; Wang C; Nan L; Gao Z; Xin Y; Li M; Shen S; Liu H; Ni X; Suo T; Zhang D; Lu P; Wang Y; Liu H
Cancer Sci; 2020 Mar; 111(3):817-825. PubMed ID: 31925976
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic activation of the elongator complex sensitizes gallbladder cancer to gemcitabine therapy.
Xu S; Jiang C; Lin R; Wang X; Hu X; Chen W; Chen X; Chen T
J Exp Clin Cancer Res; 2021 Nov; 40(1):373. PubMed ID: 34823564
[TBL] [Abstract][Full Text] [Related]
19. Identifying molecular markers for chemosensitivity to gemcitabine in pancreatic cancer: increased expression of interferon-stimulated gene 15 kd is associated with intrinsic chemoresistance.
Ina S; Hirono S; Noda T; Yamaue H
Pancreas; 2010 May; 39(4):473-85. PubMed ID: 19959962
[TBL] [Abstract][Full Text] [Related]
20. Side population cells of pancreatic cancer show characteristics of cancer stem cells responsible for resistance and metastasis.
Niess H; Camaj P; Renner A; Ischenko I; Zhao Y; Krebs S; Mysliwietz J; Jäckel C; Nelson PJ; Blum H; Jauch KW; Ellwart JW; Bruns CJ
Target Oncol; 2015 Jun; 10(2):215-27. PubMed ID: 24950733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]